We are live on ! Find out more
NV

Northpond Ventures Portfolio holdings

AUM $43.7M
1-Year Est. Return 27.27%
This Fund
S&P 500
This Quarter Est. Return
-14.93%
1 Year Est. Return
-27.27%
3 Year Est. Return
-67.31%
5 Year Est. Return
10 Year Est. Return
AUM
$286M
AUM Growth
Cap. Flow
+$298M
Cap. Flow %
104.32%
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
Reduced
Closed

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TBIO
1
DELISTED
Telesis Bio, Inc. Common Stock
TBIO
$106M 37.21%
+546,896
New +$85.1M
DICE
2
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
$83.3M 29.17%
+3,292,871
New +$96.5M
ISO
3
DELISTED
IsoPlexis Corporation Common Stock
ISO
$80.9M 28.32%
+8,805,272
New +$97.6M
CADL icon
4
Candel Therapeutics
CADL
$689M
$15.1M 5.3%
+1,935,215
New +$18.8M

Similar funds

Northpond Ventures's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Northpond Ventures, which disclosed 4 positions worth $286M. Its ten largest holdings account for 100% of the portfolio.

Its largest position is IsoPlexis Corporation Common Stock: 8,805,272 shares worth $80.9M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets.

  • Northpond Ventures's largest Q4 2021 buy was IsoPlexis Corporation Common Stock: 8,805,272 shares worth $80.9M.
  • Northpond Ventures's ten largest holdings make up 100% of its $286M portfolio in Q4 2021.
  • Northpond Ventures disclosed 4 positions in Q4 2021, its first 13F filing on record.

Based on Northpond Ventures's 13F filing for Q4 2021, filed 15 Feb 2022.